SABSSAB Biotherapeutics, Inc.
SABS holders
Who holds SAB Biotherapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
- Managers
- 107
- Shares held
- 79.2M
- Value held
- $248.1M
- Opened
- 22
- Closed
- 7
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| First PREMIER Bank | 19K | ±0% | $60 | 0.1% | Oct 13, 2026 |
| SJS Investment Consulting Inc. | 14 | New | $45 | 0% | Oct 26, 2026 |
| Root Financial Partners, LLC | 3 | New | $10 | 0% | Oct 21, 2026 |
| EverSource Wealth Advisors, LLC | 2 | New | $6 | 0% | Nov 4, 2026 |
| Toronto Dominion Bank | 300 | ±0% | $4 | 0% | Nov 16, 2026 |
| HRT Financial LP | 44.8K | New | $0 | 0% | Nov 13, 2026 |
| Virtu Financial LLC | 11.4K | −46.1% | $0 | 0% | Nov 17, 2026 |